Effect of Dapagliflozin on Myocardial Insulin Sensitivity and Perfusion: Rationale and Design of The DAPAHEART Trial.
Gian Pio SoriceFrancesca CintiLucia LeccisottiDomenico D'AmarioMargherita LorussoMaria Angela GuzzardiTeresa MezzaCamilla CocchiUmberto CapecePietro Manuel FerraroThomas F LüscherAlessandro GiordanoPatricia IozzoAndrea GiaccariPublished in: Diabetes therapy : research, treatment and education of diabetes and related disorders (2021)
EudraCT No. 2016-003614-27; ClinicalTrials.gov Identifier: NCT03313752.